Luisa Stamm, MD, PhD
Stamm is associate vice president, Infectious Disease Clinical Research, section head, HIV, Merck.
Articles
Doravirine and Islatravir Combination Shown to be Noninferior to Once-Daily ART
March 12th 2025In a blinded phase 3 study, doravirine and islatravir was compared to antiretroviral therapy, BIC/FTC/TAF (Biktarvy), and it was shown that there was no between-group differences in mean change in CD4 T-cell or total lymphocyte count at week 48.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 26th 2025 | Updated: September 3rd 2025
Biopreparedness Exercises Look to Contain High-Consequence Infectious Disease Outbreaks
Published: August 27th 2025 | Updated: September 3rd 2025
Transporting Patients With High-Consequence Infectious Disease to Special Treatment Centers
Published: August 28th 2025 | Updated: September 3rd 2025
UNC’s Global Clinical Trials Unit Attracts Researchers, Leads to Discoveries Around HIV Prevention and Treatment
Published: August 22nd 2025 | Updated: September 3rd 2025
UNC’s Institute for Global Health and Infectious Diseases Offers Research, Education, and Clinical Opportunities
Published: August 25th 2025 | Updated: September 3rd 2025
Microbiota-Based Therapies Show Superior Outcomes for Recurrent C difficile Infection
